Apple To $185? Here Are 5 Other Price Target Changes For Friday
Apple To $185? Here Are 5 Other Price Target Changes For Friday
苹果要到 185 美元？以下是周五的其他5项目标价格变化
- Keybanc raised the price target on Apple Inc. (NASDAQ:AAPL) from $177 to $185. However, Keybanc analyst Brandon Nispel maintained the stock with an Overweight. Apple shares fell 0.9% to $172.63 in pre-market trading.
- Piper Sandler raised Globant S.A. (NYSE:GLOB) price target from $231 to $249. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating on the stock. Globant shares rose 0.2% to close at $229.90 on Wednesday.
- HC Wainwright & Co. cut Nemaura Medical Inc. (NASDAQ:NMRD) price target from $12 to $8. HC Wainwright & Co. analyst Yi Chen maintained a Buy rating on the stock. Nemaura Medical shares fell 1.4% to close at $2.17 on Thursday.
- RBC Capital reduced Enviva Inc. (NYSE:EVA) price target from $78 to $76. RBC Capital analyst Elvira Scotto also downgraded the stock from Outperform to Sector Perform. Enviva shares rose 1.4% to close at $75.79 on Thursday.
- Telsey Advisory Group raised DICK'S Sporting Goods, Inc. (NYSE:DKS) price target from $110 to $125. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating on the stock. DICK'S Sporting rose 0.2% to close at $112.47 on Thursday.
- B. Riley Securities cut Gain Therapeutics, Inc. (NASDAQ:GANX) price target from $11 to $5. B. Riley Securities analyst Mayank Mamtani also downgraded the stock from Buy to Neutral. Gain Therapeutics shares fell 2.8% to close at $3.82 on Thursday.
- Keybanc将苹果公司（纳斯达克股票代码：AAPL）的目标股价从177美元上调至185美元。但是，Keybanc分析师布兰登·尼斯佩尔以 “增持” 维持该股。苹果股价在盘前交易中下跌0.9％，至172.63美元。
- 派珀·桑德勒将Globant S.A.（纽约证券交易所代码：GLOB）的目标股价从231美元上调至249美元。派珀·桑德勒分析师阿文德·拉姆纳尼维持对该股的增持评级。周三，Globant股价上涨0.2％，收于229.90美元。
- HC Wainwright & Co. 将Nemaura Medical Inc.（纳斯达克股票代码：NMRD）的目标股价从12美元下调至8美元。HC Wainwright & Co. 分析师陈毅维持该股的买入评级。周四，Nemaura Medical股价下跌1.4％，收于2.17美元。
- 加拿大皇家银行资本将Enviva Inc.（纽约证券交易所代码：EVA）的目标股价从78美元下调至76美元。加拿大皇家银行资本分析师埃尔维拉·斯科托也将该股的评级从跑赢大盘下调至板块表现。周四，Enviva股价上涨1.4％，收于75.79美元。
- 泰尔西咨询集团将迪克体育用品公司（纽约证券交易所代码：DKS）的目标股价从110美元上调至125美元。泰尔西咨询集团分析师约瑟夫·费尔德曼维持该股的跑赢大盘评级。周四，迪克体育上涨0.2％，收于112.47美元。
- B. Riley Securities将Gain Therapeutics, Inc.（纳斯达克股票代码：GANX）的目标股价从11美元下调至5美元。B. Riley Securities分析师玛雅克·马姆塔尼也将该股的评级从买入下调至中性。周四，Gain Therapeutics股价下跌2.8％，收于3.82美元。
Check out this: U.S. Stock Futures Down Ahead Of Earnings; Crude Oil Drops
看看这个：美国股票期货在财报公布前下跌；原油价格下跌